Robert K. Coughlin - Net Worth and Insider Trading

Robert K. Coughlin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert K. Coughlin owns 1 companies in total, including Aridis Pharmaceuticals Inc (ARDS) .

Click here to see the complete history of Robert K. Coughlin’s form 4 insider trades.

Insider Ownership Summary of Robert K. Coughlin

Ticker Comapny Transaction Date Type of Owner
ARDS Aridis Pharmaceuticals Inc 2018-08-13 director

Robert K. Coughlin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert K. Coughlin Ownership Network

Ownership Network List of Robert K. Coughlin

No Data

Ownership Network Relation of Robert K. Coughlin

Insider Network Chart

Robert K. Coughlin Owned Company Details

What does Aridis Pharmaceuticals Inc do?

Who are the key executives at Aridis Pharmaceuticals Inc?

Robert K. Coughlin is the director of Aridis Pharmaceuticals Inc. Other key executives at Aridis Pharmaceuticals Inc include 10 percent owner Fibrosis Foundation Cystic , Chief Medical Officer Hasan Jafri , and director & 10 percent owner & CEO & CSO & Director Vu Truong .

Aridis Pharmaceuticals Inc (ARDS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aridis Pharmaceuticals Inc (ARDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aridis Pharmaceuticals Inc (ARDS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aridis Pharmaceuticals Inc (ARDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aridis Pharmaceuticals Inc Insider Transactions

No Available Data

Robert K. Coughlin Mailing Address

Above is the net worth, insider trading, and ownership report for Robert K. Coughlin. You might contact Robert K. Coughlin via mailing address: 5941 Optical Ct., San Jose Ca 95138.

Discussions on Robert K. Coughlin

No discussions yet.